— Know what they know.
Not Investment Advice

LITH OTC

BioELife Corp.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -0.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 48 · $941 mcap · 7M float · 0.0065% daily turnover · Short 98% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
-$800 +0.0% ▲
Operating Income
-$74K +41.0% ▲
Net Income
-$337K -36.4% ▼
EPS (Diluted)
$-0.13 -30.0% ▼
EBITDA
-$74K +41.0% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2014FY2015FY2016FY2017FY2018
Revenue$0$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$396K$0$0$800$800
Gross Profit-$396K$0-$2K-$800-$800
Gross Margin—————
R&D Expenses$0$0$0$0$0
SG&A Expenses$464K$61K$104K$125K$74K
Operating Expenses$68K$61K$104K$125K$74K
Operating Income-$464K-$61K-$104K-$125K-$74K
Operating Margin—————
Interest Expense$35K$39K$106K$122K$83K
Income Before Tax-$498K-$82K-$210K-$247K-$337K
Tax Expense$0$0$0$0$0
Net Income-$498K-$82K-$210K-$247K-$337K
Net Margin—————
EPS (Diluted)$-0.44$-0.04$-0.09$-0.10$-0.13
EBITDA-$464K-$61K-$104K-$125K-$74K
Shares Outstanding1M2M2M2M3M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms